Back to results
US 2026/0158062 A1Published application
Cryoprecipitate compositions and methods of preparation thereof
AssigneeCerus Corporation
InventorsLaurence CORASH, Elan WEINER, Melody HOLTAN, Richard BENJAMIN
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and kits including a pathogen-inactivated cryoprecipitate suitable for infusion into a subject at least 1 day after thawing. The methods are useful in the efficient preparation of cryoprecipitates with desirable characteristics, including pathogen-inactivated cryoprecipitates that are suitable for infusion into a subject at least 1 day after thawing.
Claims17
1-55. (canceled)
A processing set for preparing a pathogen-inactivated cryoprecipitate, comprising
- a) a first container within which one or more units of a plasma can be photochemically inactivated in the presence of a psoralen under sterile conditions;
- b) a compound absorption device (CAD) coupled to the first container such that the one or more units of plasma can be transferred from the first container to the CAD under sterile conditions;
- c) one or more second containers, each of which is coupled to the CAD such that the one or more units of plasma can be transferred from the CAD to the one or more second containers under sterile conditions to provide pathogen-inactivated plasma suitable for infusion into a subject;
- and
- d) a third container, which is configured to be coupled to the one or more second containers such that the pathogen-inactivated plasma can be transferred from the one or more second containers to the third container under sterile conditions,
- wherein the third container is suitable for freezing the pathogen-inactivated plasma followed by thawing of the pathogen-inactivated plasma under conditions that provide for the formation of a cryoprecipitate and a cryosupernatant.
3 more elements
Dependencies are inferred from the claim text.